chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ED to Hosp-Admission Discharged  4/16/2021 - 4/20/2021 (4 days)    Last attending ? Treatment team Pneumonia due to COVID-19 virus Principal problem Discharge Summary  Internal Medicine         HOSPITAL INPATIENT DISCHARGE SUMMARY HOSPITALIST GROUP .   Patient:                                                             Date: 4/20/2021 DOB:  Admission Date: 4/16/2021 MRN:        Length of stay: 4 Days PCP:  Discharging provider:     Admission diagnosis:     Primary Admission Diagnosis    Medical Problems     Hospital Problems        POA    * (Principal) Pneumonia due to COVID-19 virus Unknown         Acute on chronic renal insufficiency Yes         Diabetes mellitus type 2 in nonobese (CMS/HCC) Yes         Cardiomyopathy (CMS/HCC) Yes    Overview Addendum 3/23/2021 10:42 AM       Note: TACHY-BRADY 1/2015; EMBOLIC CVA 1/2017; SYSTEMIC ANTICOAGULATION 1/2017; NEG REGADENOSIN STRESS 6/2017;   Formatting of this note might be different from the original. Note: TACHY-BRADY 1/2015; EMBOLIC CVA 1/2017; SYSTEMIC ANTICOAGULATION 1/2017; Note: TACHY-BRADY 1/2015; EMBOLIC CVA 1/2017; SYSTEMIC ANTICOAGULATION 1/2017; NEG REGADENOSIN STRESS 6/2017; Note: TACHY-BRADY 1/2015; EMBOLIC CVA 1/2017; SYSTEMIC ANTICOAGULATION 1/2017; NEG REGADENOSIN STRESS 6/2017; Note: TACHY-BRADY 1/2015; EMBOLIC CVA 1/2017; SYSTEMIC ANTICOAGULATION 1/2017; NEG REGADENOSIN STRESS 6/2017;            Persistent atrial fibrillation (CMS/HCC) Yes         Acute respiratory insufficiency Yes        Hospital Course   HPI: 66-year-old male admitted with COVID-19 infection on 4/15.   COVID-19 infection: In setting of immunosuppressive therapy.  Patient was hypoxic on admission.  He was treated with remdesivir?completed 5-day course on 4/20.  Was treated with convalescent plasma. Patient was weaned off oxygen during hospital stay?his saturation was 96% on room air.  He was not getting desaturation on activit during his hospital stay. He will not require dexamethasone on discharge.   Atrial fibrillation: Patient remained in atrial flutter?patient recent pacemaker placement done.  He was having tremors in extremities and so amiodarone was decreased to 200 mg once a day after discussing with cardiology team. He will follow-up next week for device check and subsequently with electrophysiologist. He was maintained on anticoagulation for stroke prophylaxis.   Hypertension: Remained stable?patient will be off clonidine. He was advised to continue with Imdur, carvedilol, nifedipine?blood pressure was ranging between 100?140s systolic.   History of renal transplant?renal function remained stable.  Patient was maintained on immunosuppressive therapy with CellCept and tacrolimus.   Patient will discharge on 4/20?agrees with plan of care.
CHILD'S DATE OF BIRTH WRITTEN AS 2/17/2009 AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY INDIVIDUAL IDENTIFYING AS FATHER. CHILD IDENTIFIED IN IMMTRAC (#150512099) WITH DATE OF BIRTH AS 2/17/2010. CHILD TOO YOUNG FOR VACCINE IN SEPTEMBER 2021.  VAERS TO FOLLOW FOR SECOND DOSE ADMINISTERED 9/24/2021 WITH SAME WRONG YEAR OF BIRTH.
Floating sensation, tingling down L arm, lightheaded 1439- 118/63 103HR 99%RA 24RR 1445- 98/64 79HR 100%RA 100.8F tingling down R arm and fingers 1454- 97/59 78HR 98%RA 97.3F improvement of symptoms, no floating, light headedness minor tingling  DC 1506
At 6:30PM on 2/6 (29.5 hours after I received my 2nd Moderna vaccine dose), I developed a small cluster of hives on my left arm around the crease of my elbow (4-5 inches away from the injection site). The hives continued to spread outward until they covered about 25% of my arm 2-3 hours after the hives first appeared. This was the height of the pain/swelling/itchiness. The hives gradually moved upward along my arm and are currently an inch or two below my injection site (5 hours after the adverse effects began).
This spontaneous report as received from a physician via company representative refers to a 14 year old male patient. The patient pertinent medical history was unspecified. On an unknown date in August 2014, the patient was vaccinated with PROQUAD (Merck) subcutaneously. No adverse effects were reported. The patient sought medical attention with the physician. No product quality complaint (PQC) was reported for PROQUAD (Merck). Additional information has been requested.
Patient with severe eczema, Severe flare up requiring oral steroids 2 days after administration.
Initial case was received from a consumer on 27 December 2012. A female patient (age not reported, birth date reported) received an injection of FLUZONE HIGH-DOSE, Sanofi Pasteur Inc., lot number unknown, (route, site, side and number of previous doses not reported) on an unknown date. That evening post vaccination (date unspecified), the patient became "really sick", was throwing up, had fever, and muscle aches. The next day, she became worse with vomiting, muscle aches, fever, and "no energy" and she went to her family doctor. The family doctor sent the patient to the emergency room, where she was admitted to the hospital for four days (dates unspecified), under the care of "heart specialist" (name unknown). Laboratory or diagnostic tests and treatments were not reported. The patient continued to have muscle aches, headache and no energy and was following up with family doctor. The patient's past medical history and concomitant medications were not reported. The patient's outcome was reported as not recovered. Documents held by sender: None.
about 3 inches below site she had a rash/rash was about 3 inches below the injection site; below site she had a rash, It was still red; below site she had a rash, swollen, little bit of swelling; below site she had a rash, it was still little sore to touch; below site she had a rash, itchy; Second day I was still tired; had no appetite; Extreme tiredness; chilling; Small fever of 100.5; dull headache; Slept for about 12 hours; This is a spontaneous report received from a contactable consumer (patient). A 79-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in Arm Left on 28Mar2021 at age of 79-year-old (Lot Number: EN6208) at single dose for COVID-19 immunization. Medical history included a little bit asthma, pine allergy, oak allergy, food allergy, 'blood pressure', stroke. Concomitant medications included losartan taken for blood pressure; hydrochlorothiazide taken for blood pressure; omeprazole; fluticasone taken for allergy; acetylsalicylic acid (BABY ASPIRIN); vitamins. The first shot she had, she ended up with a small bruise about the size of a quarter but she did not have any bruise with the second shot. The patient just wanted to report the side effects from the second Pfizer COVID-19 vaccination. She received the second one in the afternoon on 28Mar2021. And on 29Mar2021, just a little less than 24 hours later, it was at about 13:30, she got hit with extreme tiredness and she got in the recliner and got a little blanket and then she started chilling. She did not have the shakes but she couldn't get warm. She ran a small fever of 100.5 and this was for about 4 hours. And she had a dull headache. She slept for about 12 hours out of 16 that day on 29Mar2021. And then, the second day on 30Mar2021 she was still tired and had no appetite and the third day on 31Mar2021 about 3 inches below site she had a rash, swollen and itchy and 01Apr2021 was the fourth day, but it was still sore. The swelling was way down but the rash was still there and it is still itchy. She did take paracetamol (TYLENOL) that first day for the headache and chills. The paracetamol she took was two of them and they were 8 hour arthritic dosage. When paraphrased the concern, the patient stated the rash was about 3 inches below the injection site. It was still red, little sore to the touch, most of swelling down and there was little bit of swelling and red and it had gone down on 01Apr2021. Treatment for events included paracetamol and she had laid down and slept. The outcome of rash, swollen, sore below the injection site were resolving, the red and itchy below injection site was not resolved, the outcome of other events were unknown.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a physician, via a company representative, referring to a 23 year old female patient. The patient's medical history and concurrent condition were not reported. On an unknown date, when the patient was a teenager, she was vaccinated with a dose of GARDASIL, 0.2 (units not provided) intramuscular. Concomitant medication was not reported. On an unknown date, the patient experienced cervical intraepithelial neoplasia II, after receiving the GARDASIL. The patient sought medical attention. The outcome and causality of cervical intraepithelial neoplasia II were unknown. Additional information is not expected as the reporter did not wish further contact.
pt recvd flu vax & devel a baseball sized welt @ the site of inject; redness was followed by pruritus; reaction persisted 4-5 days;
I tested positive for Covid-19 on March 11, 2023, I experienced nasal drip, sore throat, coughing, congestion. I was prescribed PAXLOVID for my symptoms.
Headache, "severe" chills, sensation of cold throughout body within 8hrs of vaccination. Stomach upset, body aches for 3 days following vaccination. Also cough. All resolved except dull headache which was present prior to vaccination.
horrible headaches; crazy dreams; chills; fever, under 101; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (horrible headaches), ABNORMAL DREAMS (crazy dreams), CHILLS (chills) and PYREXIA (fever, under 101) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced HEADACHE (horrible headaches), ABNORMAL DREAMS (crazy dreams), CHILLS (chills) and PYREXIA (fever, under 101). On 31-Mar-2021, HEADACHE (horrible headaches), ABNORMAL DREAMS (crazy dreams), CHILLS (chills) and PYREXIA (fever, under 101) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
purple patches appeared on 1/30/2021 and got worse on 2/02/2021, went to ED, diagnosed with Levido Reticularis. Given methyl prednisone 125mg IM and Ketorolac 60mg IM and a prescription for prednisone. Symptoms decreased after a couple of hours and came back on 2/4/2021. Went to health clinic and received another steroid shot.
On the 7th day, Nicolas developed a fever of 101 degrees.  It lasted for 4 days and got as hight as 103.5.  It finally subsided on the 4th day, then he developed a red prickly rash that covered is face, chest and neck.
Hospitalized with syncope, Probably vasovagal response.  covid positive without respiratory symptoms.
Information has been received from a physician concerning a 9 year old female with no allergies or medical history who on 03Oct1995 was vaccinated with a dose of varicella virus vaccine live. Subsequently the child was exposed at school and developed chickenpox. At the physician's office on 13Apr04, the pt was given acyclovir (Zovirax). The reporter also mentioned another child who received varicella virus vaccine live and developed an adverse experience (WAES0404USA01944). Additional information has been requested.
The third IPV given on 06/25/10 at about 12 pm, within about 1 minutes after the shot the patient fainted and fell on the floor, but with a support of the MA who gave the shot; pt. shook body 1 time. The pulse is well palpable and woke up within 1 minute. O2 was given 2 liters/min and patient completely woke up within seconds, then became alert well responsive pink BP is stable.
Within hours of receiving vaccination, experienced severe chills, fever, sweating, headache, nausea, and body aches to the point of not being able to move. This continued for the next 24 hours and mostly subsided by day 3. However, started developing SOB, what felt like chest palpitations, dizziness/vertigo, and bilateral numbness/tingling in upper extremities accompanied by tremors/shaking of arms. Would find myself out of breath simply walking up one flight of stairs in the house. Finally went to MD office 15 days later to undergo tests including CBCw/Diff, CMP, CK total and CKMB, chest x-ray, high sensitivity Troponin I, and D-Dimer. Results came back WNL with exception of elevated CO2 and was advised to follow up again if symptoms continued.  During this time we were moving so did not have new MD. Symptoms continued and at one point when staying at in-laws while looking for homes, fainted in driveway. To this day still experience intermittent bilateral tingling/numbness and shaking/tremors in upper extremities, SOB, and what feels like palpitations or best described as something "weighing" on the heart. Vertigo has also continued and been an ongoing issue.
Within 12 hours of receiving the vaccine, I developed a fever of 101, body aches, and sweats. This continued for the next 24 hours and then I had chills. I also was weaning from breastfeeding, however during the time of symptoms I was lactating, which was not happening prior to receiving the vaccine. Symptoms remained for a total of 36 hours.
Herpes Zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation refers to a currently 70-year-old female patient. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On approximately (reported as "on or around") 30-SEP-2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not provided) for long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient experienced herpes zoster, for which she was treated by a healthcare provider. The outcome of herpes zoster was not provided. The reporter considered herpes zoster to be related to zoster vaccine live (ZOSTAVAX).     Additional information has been requested.
Large local reaction (red patch sl raised on (R) thigh after DTaP. Smaller red patch (L) thigh after Varicella.
I got a shot 3 years ago, then/ got another 11 months ago, and a third twp days ago.; got a shot 3 years ago, then because of shortages, got another 11 months ago; got a shot 3 years ago, then/ got another 11 months ago, and a third twp days ago.; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first shot on an unknown date 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix and the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced drug dose administration interval too long, product supply issue and extra dose administered. On an unknown date, the outcome of the drug dose administration interval too long, product supply issue and extra dose administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. This case was reported by patient herself/himself. The patient had got Shingrix shot 3 years ago and then because of shortage got another 11 month ago which led to lengthening of vaccination schedule and product supply issue. The patient had received third dose of Shingrix two days ago after second dose which led to extra dose administered. The patient asked about should he/she get the fourth dose. The reporter not sure about the follow up.
MEDICAL ASSISTANT THOUGHT THE PROVIDER SAID A SHINGRIX AND COVID VACCINE PT SAID  pneumonia  and covid gave third zhingrix and pt did not need it
This spontaneous report was received from a physician via Pfizer (MFR # 2015305092), and refers to a 67 year old female patient allergic to sulfa. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, frequency, route, anatomic site of administration, lot # and expiration date were not reported). No concomitant medications were reported. On an unknown date, after the PNEUMOVAX 23 administration, the patient experienced an allergy, fever, vomiting and welts at the injection site. At the time of the report, the outcome of all events was unknown. The relatedness between the events and the PNEUMOVAX 23 was not provided. Additional information has been requested.
Patient states her left arm was sore and could not hardly move, the pain radiated from arm up to her ear after receiving vaccine. Patient instructed to use cold compress and take pain medicine. If the pain is not releived instructed to see PCP.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Hypertension-Medium, Systemic: Nausea-Severe, Additional Details: Patient was given the Pfizer Covid-19 Vaccine. About 2-5 minutes after receiving the patient stated he felt a "headache" and immediately lost consciousness. Patient was seated and slowly slid out of chair. When I got to the patient it looked as though patients eyes were fluttering and he was not responsive the first 5-10 seconds of me laying patient on back and elevating feet. Patiend suddenly came to after about 15 seconds total and was responsive to all questions. vitals were taken.
A big red spot on my arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of erythema of extremities in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of injection site pain (on an unknown date the patient received the 1st dose and felt pain of the needle, refer case US2023AMR052227).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced erythema of extremities (Verbatim: A big red spot on my arm). The outcome of the erythema of extremities was resolved.   It was unknown if the reporter considered the erythema of extremities to be related to Shingles vaccine.     It was unknown if the company considered the erythema of extremities to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR052227   Additional Information: GSK Receipt Date: 07-APR-2023 This case was reported the patient via interactive digital media. The patient got a big red spot on his/her arm. But it was only for a couple days. Way better than getting shingles. This case is linked with US2023AMR052243 and US2023AMR052242, reported by the same reporter. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR052227:same reporter - 1st dose US-GSK-US2023AMR052242:same reporter US-GSK-US2023AMR052243:same reporter
Patient states approximately 16 hours post vaccination she experienced dizziness which caused her to pass out. She described herself as incoherent and having seizing like reactions. Patient said that symptoms resolved about an hour after onset. Patient states to not have any reaction to previous doses.
Cellulitis 3 days post vaccination.  TX at local Emergency Room Clyndamycin IV and Tyl 325mg PO PRN for Pain
pt cont to cry p/vax & became unable to comfort later that afternoon into noc, inc temp;APAP given every 4hr leg red, swollen @ site;pt quieted p/MN same day;site inflamed x 24-36hr;
Patient got Janssen vaccine at our pharmacy on Friday 5/7/2021. When we tried to enter it into our state vaccine registry that evening, it showed that the patient had received a Moderna vaccine at a local doctor's office on Friday, April 30th. (exactly 1 week prior). We checked with the doctor's office yesterday and confirmed that he did indeed get the Moderna vaccine there on April 30th.
Severe stabbing stomach pain, belly button to whole right side, pain level 8. Relieved pain by laying on right side it would gradually improve over 30 minutes. Any movement and pain would immediately spike to pain level 8 again - laying right side would again slowly alleviate over next half hour. Stayed in bed all day, except to eat. Lasted for 24 hours.
p/vax pt devel fever of 102.7; aching joints; severe h/a lasting 3 days;
Patient received two Pfizer covid vaccine, and both times PT got Shingles after each injection.
Began with fatigue about 4 hours after vaccine.  Fatigue worsened and began to have body aches after about 7 hours.  Then I began to have severe headaches, body aches, chills and fever all night.  Was extremely fatigued the next day as well as aches and chills.  After about 36 hours, all symptoms were gone.
Pt felt lightheaded and fainted.  Some LUE tonic/clonic movement, eyes rolled back, head turned to R.  This episode lasted less than 10 sec.  Pt was pale, diaphoretic with nausea.  Monitor pt for 30 min.  BP 116/68 - 104/70 HR 52, lips pink, good cap. refill - color improved, sm. sip of cl. liquid.  D/C home with mom.
p/vax pt exp myalgias; shaky chills; significant h/a; tx w/motrin & rest; lymerix discontinued
Patient had chills 12 hours after receiving 2nd dose; fever; Bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Patient had chills 12 hours after receiving 2nd dose), PYREXIA (fever) and MYALGIA (Bodyaches) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Patient had chills 12 hours after receiving 2nd dose), PYREXIA (fever) and MYALGIA (Bodyaches). At the time of the report, CHILLS (Patient had chills 12 hours after receiving 2nd dose), PYREXIA (fever) and MYALGIA (Bodyaches) outcome was unknown.            Reporter did not allow further contact
patient stated numbness in arm that comes and goes during the day and chest pressure in the back that has been there since receiving the vaccine
79 Male received both doses of Pfizer. Developed symptoms -  SOA, decreased activity, generalized weakness, decreased P. O. intake. Tested PCR positive 4/26/2021 & serology 4/29/2021. Hospitalized 4/27/2021. Diagnosis at time of death: Hypoxic ARF requiring MV, COVID-19 PNA, rule out superimposed bacterial PNA, renal failure, oliguric, metabolic acidosis. CWP/COPD exacerbation, CAD, DM present on admission
Blood, bright red, and "a good amount of it" per mom. In stool x 2-3 days. No fussiness. Self-resolved. Never brought to our attention until today.
24 hours after Tdap, developed two pinpoint sized red macules & few pinpoint sized vesicles around injection site. Slight lateral deltoid edema. Was itchy. Resolved in 24 hours.
Seizure, high fever of 104 with Tylenol, extreme chills, loss of consciousness
12/08/21 presents to ED for "hypoxia and SOB". PMHx of "hypothyroidism, influenza ARDS, obesity"